BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.
Poussard M, Philippe L, Fredon M, Bôle-Richard E, Biichle S, Renosi F, Perrin S, Kroemer M, Limat S, Bonnefoy F, Daguindau E, Deconinck E, Gruson B, Saas P, Adotévi O, Garnache-Ottou F, Angelot-Delettre F.
Poussard M, et al. Among authors: gruson b.
EJHaem. 2020 Dec 13;2(1):125-130. doi: 10.1002/jha2.149. eCollection 2021 Feb.
EJHaem. 2020.
PMID: 35846081
Free PMC article.